BR0312568A - Composições gastrointestinais compreendendo derivados de gaba - Google Patents

Composições gastrointestinais compreendendo derivados de gaba

Info

Publication number
BR0312568A
BR0312568A BR0312568-8A BR0312568A BR0312568A BR 0312568 A BR0312568 A BR 0312568A BR 0312568 A BR0312568 A BR 0312568A BR 0312568 A BR0312568 A BR 0312568A
Authority
BR
Brazil
Prior art keywords
gastrointestinal
compositions
gaba derivatives
gastrointestinal compositions
gaba
Prior art date
Application number
BR0312568-8A
Other languages
English (en)
Inventor
Arthur Anthony Ciociola
Catherine Ann Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/193,640 external-priority patent/US20040010034A1/en
Priority claimed from US10/196,060 external-priority patent/US20040010035A1/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0312568A publication Critical patent/BR0312568A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSIçõES GASTROINTESTINAIS COMPREENDENDO DERIVADOS DE GABA". A presente invenção refere-se a composições e métodos para o tratamento e/ou prevenção de distúrbios gastrointestinais (GI) da parte inferior em doentes mamíferos, mais particularmente para o alívio e/ou prevenção de sintomas Gi da parte inferior associados com distúrbios.
BR0312568-8A 2002-07-10 2003-06-30 Composições gastrointestinais compreendendo derivados de gaba BR0312568A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/193,640 US20040010034A1 (en) 2002-07-10 2002-07-10 Gastrointestinal compositions
US10/196,060 US20040010035A1 (en) 2002-07-15 2002-07-15 Gastrointestinal compositions
PCT/IB2003/003156 WO2004006901A1 (en) 2002-07-10 2003-06-30 Gastrointestinal compositions comprising gaba derivatives

Publications (1)

Publication Number Publication Date
BR0312568A true BR0312568A (pt) 2005-05-03

Family

ID=30117823

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312568-8A BR0312568A (pt) 2002-07-10 2003-06-30 Composições gastrointestinais compreendendo derivados de gaba

Country Status (7)

Country Link
EP (1) EP1549302A1 (pt)
JP (1) JP2005533100A (pt)
AU (1) AU2003247042A1 (pt)
BR (1) BR0312568A (pt)
CA (1) CA2491721A1 (pt)
MX (1) MXPA05000405A (pt)
WO (1) WO2004006901A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007505095A (ja) * 2003-09-12 2007-03-08 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー うつ病及び不安障害の治療のためのアルファ−２−デルタリガンド及びｓｓｒｉ及び／又はｓｎｒｉを含む組み合わせ
US8060050B2 (en) 2004-06-04 2011-11-15 Broadcom Corporation Method and system for analog and digital RF receiver interface
ITMI20041447A1 (it) * 2004-07-20 2004-10-20 Zambon Spa Composizione farmaceutica comprendente gabapentina
CN107582521A (zh) * 2017-09-27 2018-01-16 江西省子轩科技有限公司 一种稳定性好的乙酰谷酰胺注射液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460919A1 (fr) * 1979-07-11 1981-01-30 Prod Synthese Ste Indle Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
US6127418A (en) * 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
AU8668598A (en) * 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage

Also Published As

Publication number Publication date
AU2003247042A1 (en) 2004-02-02
JP2005533100A (ja) 2005-11-04
EP1549302A1 (en) 2005-07-06
WO2004006901A1 (en) 2004-01-22
CA2491721A1 (en) 2004-01-22
MXPA05000405A (es) 2005-03-23

Similar Documents

Publication Publication Date Title
BR0008447A (pt) Métodos de tratamento de distúrbios mitocondriais
WO2007127505A3 (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
BR0313282A (pt) Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia
GEP20084520B (en) Use of retinyl derivatives and compositions thereof for treating ophthalmic diseases
HK1057330A1 (en) Use of hydroxyethylrutosides for treating symptomsof common cold, allergic rhinitis and infections relating to the respiratory tract
ATE417607T1 (de) Sphingolipide gegen krankhafte prozesse in lipid rafts
BRPI0506970A (pt) derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior
AUPS057102A0 (en) Compositions and methods for treatment of skin disorders
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
BR0307951A (pt) Co-terapia para o tratamento de enxaqueca compreendendo derivados de anticonvulsivantes e agentes antienxaqueca
TNSN05131A1 (en) New synergistic combination comprising roflumilast and formoterol
BR0312568A (pt) Composições gastrointestinais compreendendo derivados de gaba
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
BR0312501A (pt) Combinação de um inibidor alostérico ou metaloproteinase de matriz-13 com um inibidor de ciclooxigenase-2 diferente de celecoxib ou valdecoxib
WO2004035082A3 (en) Proteins involved in the regulation of energy homeostasis
BR0108823A (pt) Composição farmacêutica para o tratamento da doença cerebrovascular cognitiva
ATE545428T1 (de) Pik4cb involviert in der regulierung des energiestoffwechsels
WO2003092715A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004020465A3 (en) Proteins involved in the regulation of energy homeostasis
BR0306167A (pt) Processo de obtenção de extratos de casearia sylvestris, processos de obtenção de frações ativas, extratos, frações ativas, uso de extratos e frações ativas, composição, unidade de dosagem, método para prevenir, tratar, combater ou suspender distúrbios gastrintestinais, medicamento e principio ativo
WO2004016641A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004047855A3 (en) Proteins involved in the regulation of energy homeostasis
WO2006107902A8 (en) Use of spirostenols to treat mitochondrial disorders
WO2003084566A3 (en) Proteins involved in the regulation of energy homeostasis
WO2004002513A3 (en) Proteins involved in the regulation of energy homeostasis

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE 5A., 6A. E 7A. ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2064 DE 27/07/2010.